MTEC Awards $3M to Astrocyte Pharmaceuticals for Clinical Study of AST-004

MTEC Awards $3M to Astrocyte Pharmaceuticals for Clinical Study of AST-004

Astrocyte Pharmaceuticals Inc., a drug discovery and development company advancing novel neuroprotective therapeutics for the treatment of neurodegenerative brain injuries, announced today the granting of a $3.0M award from the Medical Technology Enterprise Consortium (MTEC). Read more >> 

Share this post